The serum concentration of folate is an important marker of nutritional status and has been measured for Ͼ30 years as part of the National Health and Nutrition Examination Survey (NHANES). The Bio-Rad QuantaPhase II radioassay (BR) has been used since 1991 but will be discontinued in 2007. The introduction of mandatory folic acid (FA) fortification in 1998 has contributed to appreciable increases in serum folate concentrations in the US population (1 ); continued monitoring through NHANES is required. Two assays have been discussed for future surveys: the new isotope-dilution liquid chromatography-tandem mass spectrometry method (LC-MS/MS) (2, 3 ) and the traditional Lactobacillus casei microbiologic assay (MA) (4, 5 ) . The LC-MS/MS measures 5 folate species: 5-methyltetrahydrofolic acid (5CH 3 THF), FA, 5-formyltetrahydrofolic acid (5CHOTHF), tetrahydrofolic acid (THF), and 5,10-methenyltetrahydrofolic acid (5,10CHϭTHF). The MA and BR measure total folate (TFOL). The 1st objective of this study was to compare the LC-MS/MS method with the traditional MA. The 2nd objective was to provide equations for converting results from the assay currently used for the NHANES (BR) to the new assay for future analyses (MA or LC-MS/MS).
Pristine serum samples (n ϭ 237) collected as part of the NHANES from 1999 to 2004 and stored at Ϫ70°C were analyzed between December 2005 and February 2006 for folate species by the LC-MS/MS and for TFOL by the MA. The BR has analyzed aliquots of the same samples for TFOL from 1999 to 2004. These samples are not representative of the US population. They were selected to cover a wide range of TFOL concentrations, as measured by the BR assay. The second set of samples consisted of 100 pristine serum samples obtained from a blood bank from January to March 2006. These samples were analyzed by all 3 assays in March and April 2006.
Data were analyzed with SAS (version 9; SAS Institute) and Microsoft Excel with a clinical statistical analysis plug-in (Analyse-it; Analyse-it Software). Two NHANES samples were excluded as outliers because of an extremely high concentration of either 5CHOTHF or FA. The sample sets were analyzed first separately and then together. We used the sum of the folate species determined by the LC-MS/MS and TFOL determined by the MA or BR to compare the methods. Results are presented only for the combined set because we found no differences between the 2 data sets other than the concentration ranges (see Fig. 1 in the Data Supplement that accompanies the online version of this Technical Brief at http:// www.clinchem.org/content/vol53/issue4). Methods were compared by least-squares regression after log-transformation of the data to account for nongaussian distribution. The concentration-dependent relationship between these assays prompted us to develop multiple linear regression models that used a dummy binary variable (0, 1), IND, to account for intercept differences and an interaction variable (IND ϫ log 10 BR or IND ϫ log 10 MA) to account for differences in slope over 2 discrete concentration ranges (Յ45 vs Ͼ45 nmol/L for the BR and Ͻ50 vs Ն50 nmol/L for the MA). The fit of the models was evaluated by comparing the sum of squared residuals (SSR) to the predicted residual sum of squares (PRESS). We tested the recoveries of the MA and BR methods (n ϭ 2 days) by adding each of the 5 folate calibrators (Merck Eprova) at 10 nmol/L to a serum pool (21.8 nmol/L TFOL by LC-MS/MS).
The mean concentrations for TFOL, 5CH 3 THF, and FA were higher in the NHANES set than in the blood bank
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Clinical Chemistry 53, No. 4, 2007 set, whereas the mean 5CHOTHF concentration was higher in the blood bank set (Table 1 ). In the combined set, the major folate forms were 5CH 3 THF (82%) and FA (8%). Most samples had only low FA (Ͻ2.5 nmol/L) and 5CHOTHF (Ͻ10 nmol/L) concentrations. Approximately half the samples had detectable THF concentrations; only 10% had THF concentrations Ͼ10 nmol/L.
Mean and median TFOL concentrations measured by LC-MS/MS and MA were generally in agreement, but BR values were much lower. The sum of folate species and TFOL determined by the LC-MS/MS and the MA, respectively, were highly correlated (R 2 ϭ 0.97), but the latter produced slightly lower results, corresponding to a small but significant negative concentration-dependent difference of Ϫ5.94 nmol/L (95% confidence interval, Ϫ7.49 to Ϫ4.39 nmol/L) and a relative difference of Ϫ6%. (Fig. 1, B and C) .
In The lower response of the BR compared with the MA has been known for many years (7 ). The BR was initially marketed (QuantaPhase I) with calibrator concentrations to match MA performance, but questions raised by Levine (8 ) The BR or MA is used as the reference point (n ϭ 325). The concentrationdependent relationship between these assays prompted our development of a multiple linear regression model that accounts for a change in slope and/or intercept over 2 discrete concentration ranges (Յ45 vs Ͼ45 nmol/L by the BR and Ͻ50 vs Ն50 nmol/L for the MA). The fit of the model was evaluated by comparing the SSR with the PRESS.
results between these 2 methods is not clinically relevant. Irrespective of the assay used for future NHANES monitoring, population reference ranges will change to higher values; however, MA-determined cutoff values for deficiency (10 ) could be directly applied to the LC-MS/MS because of its excellent agreement with the MA. Some advantages of the LC-MS/MS compared with the MA are that it provides information on the different folate species in addition to TFOL and it is less prone to interferences such as antibiotics. BR underrecovery of 5CH 3 THF, the main circulating form of folate, is likely the major reason for its lower results. A model will be required to convert results from the old or the new NHANES method for time trend analysis. Our model provides an excellent fit over a wide concentration range. This information may also be useful to the international community in that national data generated with the MA can now potentially be compared with US reference ranges.
